← Back to Search

Other

Melatonin 5mg for Delirium (MICE Trial)

Phase 4
Waitlist Available
Research Sponsored by MICE Trial Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Non-ventilated Patients over the age of 65
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days post d/c
Awards & highlights

MICE Trial Summary

The investigators are studying the use of Melatonin in non-ventilated patients over the age of 65. Primary endpoint will be assesments of delirium, with secondary endpoints to include length of stay, use of anti-psychotic medications, and mortality

Eligible Conditions
  • Delirium
  • Melatonin

MICE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

MICE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days post d/c
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days post d/c for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Delirium
Secondary outcome measures
30 day mortality
90 day mortality
Average RASS Score
+3 more

MICE Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Melatonin 5mgActive Control1 Intervention
This arm will be given 5mg tablets of Melatonin nightly for the duration of their hospital stay
Group II: Melatonin 3mgActive Control1 Intervention
This arm will be given 3mg tablets of Melatonin nightly for the duration of their hospital stay
Group III: PlaceboPlacebo Group1 Intervention
This arm will be given a Sucrose tablet nightly for the duration of their hospital stay

Find a Location

Who is running the clinical trial?

MICE Trial GroupLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Melatonin Use in the Intensive Care Elderly Population
2016. "Melatonin Use in the Intensive Care Elderly Population". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03013790.
All > Melatonin
~72 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top